Translational genomics and targeted therapies in solid tumours
Featured projects
-
A European Cancer Image Platform Linked to Biological and Health
Principal investigator: Aleix Prat Aparicio.Funder: Horizon 2020 Framework Programme .Code: 952103 — EuCanImage.Duration: 01/10/2020 - 30/09/2024Identification of mechanisms of response to CDK4/6 inhibition in hormone receptor-positive breast cancer
Principal investigator: Aleix Prat Aparicio.Funder: IRB (Participante); Fundació La Marató de TV3 ; IDIBELL (Participante); IDIBAPS (Sede).Code: 201935-30-31-32.Duration: 30/07/2020 - 29/07/2023Summary:Hormone receptor–pos
RESCUER. Resistance Under Combinatorial Treatment in ER+ and ER- Breast Cancer.
Principal investigator: Aleix Prat Aparicio.Funder: Horizon 2020 Research and Innovation Framework Programme .Code: H2020-SC1-BHC-02-2019 / 847912-2.Duration: 01/01/2020 - 31/12/2024Targeting immune checkpoints and metabolic reprogramming synergic vulnerabilities in metastatic colorectal cancer (IMMETCOL)
Principal investigator: Joan Maurel.Funder: Instituto de Salud Carlos III (Sede).Duration: 01/01/2020 - 01/01/2022Adoptive cell therapy using CD3+/PD1+ tumor infiltrating lymphocytes in patients with advanced breast cancer
Principal investigator: Aleix Prat Aparicio.Funder: AECC, Fundación Científica Asociación Española Contra el Cáncer ; Hospital Clinic de Baarcelona (Participante); Clínica Universidad de Navarra (Participante); Vall d'Hebron Institut d'Oncologia (Participante); HOSPITAL UNIVERSITARIO 12 DE OCTUBRE (Partic.Code: GCAEC19010PRAT.Duration: 01/12/2019 - 30/11/2024Treatment of advanced breast cancer with adoptive therapy of CD3+/PD1+ tumor infiltrating lymphocytes
Principal investigator: Aleix Prat Aparicio.Funder: Fundacion AECC .Duration: 15/09/2019 - 14/09/2022AACR 2019 - Tailoring systemic treatment of Luminal B breast cancer
Principal investigator: Patricia Galvan, Aleix Prat Aparicio.Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research .Code: BCRF_AACR_18_001.Duration: 01/07/2019 - 30/06/2021Caracterización de los linfocitos T CD8+/PD1+ en cáncer de mama avanzado receptor hormonal-positivo con un fenotipo agresivo HER2-enriched.
Principal investigator: Aleix Prat Aparicio.Funder: Merck Farma y Química, S.L .Code: 19-IO-011.Duration: 01/07/2019 - 30/06/2021Prospective exploratory study for determination of circulating tumor DNA (ctDNA) in blood samples from patients treated for breast cancer in follow-up and without evidence of relapse (B-CRONOS) KEYWORDS : Breast cancer, ctDNA, luminal, high risk
Principal investigator: Aleix Prat Aparicio.Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Fundación Quiron Salaud ; Fundación Quirón Salud .Code: TERAPIA_AMIGOS_18_01.Duration: 11/02/2019 - 10/02/2022Targeting the HER2-enriched phenotype in hormone receptor-positive breast cancer. Breast Cancer Now (Breast Cancer Now)
Duration: 01/01/2019 - 01/01/2022Major founders
The research of this group can be carried out thanks to the funders.
-
. This link opens in a new tab. AGAUR
-
. This link opens in a new tab. American Association for Cancer Research
-
. This link opens in a new tab. Asociación Española Contra el Cáncer
-
. This link opens in a new tab. Breast Cancer Now
-
. This link opens in a new tab. Breast Cancer Research Foundation
-
. This link opens in a new tab. European Commission
-
. This link opens in a new tab. Fundació La Marató de TV3
-
. This link opens in a new tab. Fundación Eugenio Rodríguez Pascual
-
. This link opens in a new tab. Fundación Merk Salud
-
. This link opens in a new tab. Fundación Mutua Madrileña
-
. This link opens in a new tab. Fundación Quirónsalud
-
. This link opens in a new tab. Instituto de Salud Carlos III
-
. This link opens in a new tab. National Breast Cancer Foundation
-
. This link opens in a new tab. SEOM
-
. This link opens in a new tab. SOLTI
-
. This link opens in a new tab. University of Michigan
Contributors
Donations that make possible the research of this group.
-
. This link opens in a new tab. Asociación Cáncer de Mama Metastásico
-
. This link opens in a new tab. Fundación AstraZeneca
-
. This link opens in a new tab. Fundación Fero
-
. This link opens in a new tab. Fundación Invi
-
. This link opens in a new tab. Help&Run
-
. This link opens in a new tab. Mi grano de arena
-
. This link opens in a new tab. Pas a pas
-
. This link opens in a new tab. Save the Mama
-
. This link opens in a new tab. Xemio
-
. This link opens in a new tab. gAmis
More about researchCheck job offersIDIBAPS-FCRB looks for talented professionals to meet the needs that appear periodically.
Enter